Advertisement
Screener

SCIENTURE HOLDINGS, INC. (SCNX) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

SCIENTURE HOLDINGS, INC. Financing Cash Flow

SCIENTURE HOLDINGS, INC. (SCNX) reported Financing Cash Flow of $10.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13

  • SCIENTURE HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $10.79M.
  • SCIENTURE HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$200.00K, a 104.26% decline year-over-year.
  • SCIENTURE HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $11.48M, a 311.53% increase year-over-year.
  • SCIENTURE HOLDINGS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $3.55M.
  • SCIENTURE HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $19.73M.
  • SCIENTURE HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2024 was -$12.98M, a 1022.95% decline from fiscal 2023.
  • SCIENTURE HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $1.41M.
  • SCIENTURE HOLDINGS, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$35.17K.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30$10.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$10.59M
10-Q · filed 2026-08-13
$22.07M
derived: sum of 3 quarters · filed 2026-08-13
$25.63M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$200.00K
10-Q · filed 2026-05-15
$11.28M
derived: sum of 2 quarters · filed 2026-05-15
$14.84M
derived: sum of 3 quarters · filed 2026-05-15
$14.84M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$11.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$15.04M
derived: sum of 2 quarters · filed 2026-03-30
$15.04M
derived: sum of 3 quarters · filed 2026-08-13
$19.73M
10-K · filed 2026-03-30
2025-09-30$3.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$3.55M
derived: sum of 2 quarters · filed 2026-08-13
$8.25M
10-Q · filed 2025-11-12
$11.04M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$4.70M
10-Q · filed 2026-08-13
$7.49M
derived: sum of 3 quarters · filed 2026-08-13
$5.61M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$4.70M
10-Q · filed 2026-05-15
$7.49M
derived: sum of 2 quarters · filed 2026-05-15
$5.61M
derived: sum of 3 quarters · filed 2026-05-15
$5.61M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$2.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$916.24K
derived: sum of 2 quarters · filed 2026-03-30
$916.24K
derived: sum of 3 quarters · filed 2026-03-30
-$12.98M
10-K · filed 2026-03-30
2024-09-30-$1.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
-$1.87M
derived: sum of 2 quarters · filed 2025-11-12
-$15.77M
10-Q · filed 2025-11-12
-$14.43M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$13.90M
10-Q · filed 2025-08-12
-$12.56M
derived: sum of 3 quarters · filed 2025-08-12
-$12.45M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$13.90M
10-Q · filed 2025-05-12
-$12.56M
derived: sum of 2 quarters · filed 2025-05-12
-$12.45M
derived: sum of 3 quarters · filed 2025-05-12
-$13.17M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$1.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
$1.45M
derived: sum of 2 quarters · filed 2025-03-26
$725.08K
derived: sum of 3 quarters · filed 2025-03-26
$1.41M
10-K · filed 2025-03-26
2023-09-30$114.96K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$610.32K
derived: sum of 2 quarters · filed 2024-11-06
$70.93K
10-Q · filed 2024-11-06
-$232.25K
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30-$725.28K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
-$44.02K
10-Q · filed 2024-08-09
-$347.21K
derived: sum of 3 quarters · filed 2024-08-09
-$355.07K
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$681.26K
10-Q · filed 2024-06-26
$378.07K
derived: sum of 2 quarters · filed 2024-06-26
$370.21K
derived: sum of 3 quarters · filed 2024-06-26
$920.21K
derived: sum of 4 quarters · filed 2024-06-26
2022-12-31-$303.19K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
-$311.05K
derived: sum of 2 quarters · filed 2024-01-16
$238.95K
derived: sum of 3 quarters · filed 2024-01-16
-$35.17K
10-K · filed 2023-03-27
2022-09-30-$7.86K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-16
$542.14K
derived: sum of 2 quarters · filed 2024-01-16
$268.02K
10-Q · filed 2024-01-16
$268.02K
derived: sum of 4 quarters · filed 2024-01-16
2022-06-30$550.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-18
$275.88K
10-Q · filed 2023-08-18
$275.88K
derived: sum of 3 quarters · filed 2023-08-18
$65.88K
derived: sum of 4 quarters · filed 2023-08-18
2022-03-31-$274.13K
10-Q · filed 2023-05-15
-$274.13K
derived: sum of 2 quarters · filed 2023-05-15
-$484.12K
derived: sum of 3 quarters · filed 2023-05-15
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27
-$210.00K
derived: sum of 2 quarters · filed 2023-03-27
-$208.18K
10-K · filed 2023-03-27
2021-09-30-$210.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
-$208.18K
10-Q · filed 2022-11-07
2021-06-30$1.82K
10-Q · filed 2022-07-25
2020-12-31$1.35K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28
$14.65K
derived: sum of 2 quarters · filed 2022-03-28
$36.25K
derived: sum of 3 quarters · filed 2022-03-28
$5.30M
10-K · filed 2022-03-28
2020-09-30$13.30K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-25
$34.90K
derived: sum of 2 quarters · filed 2021-10-25
$5.30M
10-Q · filed 2021-10-25
$5.08M
derived: sum of 4 quarters · filed 2021-10-25
2020-06-30$21.60K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-26
$5.29M
10-Q · filed 2021-07-26
$5.06M
derived: sum of 3 quarters · filed 2021-07-26
$7.48M
derived: sum of 4 quarters · filed 2021-07-26
2020-03-31$5.26M
10-Q · filed 2021-04-26
$5.04M
derived: sum of 2 quarters · filed 2021-04-26
$7.46M
derived: sum of 3 quarters · filed 2021-04-26
$7.46M
derived: sum of 4 quarters · filed 2021-04-26
2019-12-31-$222.55K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29
$2.19M
derived: sum of 2 quarters · filed 2021-03-29
$2.19M
derived: sum of 3 quarters · filed 2021-03-29
$2.19M
10-K · filed 2021-03-29
2019-09-30$2.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26
$2.42M
derived: sum of 2 quarters · filed 2020-10-26
$2.42M
10-Q · filed 2020-10-26
$2.92M
derived: sum of 4 quarters · filed 2020-10-26
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27
$166.00
10-Q · filed 2020-07-27
$500.17K
derived: sum of 3 quarters · filed 2020-07-27
$800.17K
derived: sum of 4 quarters · filed 2020-07-27
2019-03-31$166.00
10-Q · filed 2020-05-04
$500.17K
derived: sum of 2 quarters · filed 2020-05-04
$800.17K
derived: sum of 3 quarters · filed 2020-05-04
$738.44K
derived: sum of 4 quarters · filed 2020-05-04
2018-12-31$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$800.00K
derived: sum of 2 quarters · filed 2020-03-30
$738.27K
derived: sum of 3 quarters · filed 2020-03-30
$677.54K
10-K · filed 2020-03-30
2018-09-30$300.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28
$238.28K
derived: sum of 2 quarters · filed 2019-10-28
$177.54K
10-Q · filed 2019-10-28
2018-06-30-$61.73K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26
-$122.46K
10-Q · filed 2019-07-26
2018-03-31-$60.74K
10-Q · filed 2019-05-13
2017-12-31-$2.44K
10-K · filed 2019-03-22
2017-03-31$203.60K
10-Q · filed 2017-05-15
2016-09-30$486.49K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$791.49K
derived: sum of 2 quarters · filed 2016-11-14
$791.49K
10-Q · filed 2016-11-14
$1.74M
derived: sum of 4 quarters · filed 2017-05-15
2016-06-30$305.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$305.00K
10-Q · filed 2016-08-05
$1.26M
derived: sum of 3 quarters · filed 2017-05-15
$1.26M
derived: sum of 4 quarters · filed 2017-05-15
2016-03-31$0.00
10-Q · filed 2017-05-15
$951.67K
derived: sum of 2 quarters · filed 2017-05-15
$951.67K
derived: sum of 3 quarters · filed 2017-05-15
2015-12-31$951.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28
$951.67K
derived: sum of 2 quarters · filed 2016-11-14
$1.36M
10-K · filed 2016-03-28
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
$405.00K
10-Q · filed 2016-11-14
2015-06-30$405.00K
10-Q · filed 2016-08-05
2014-12-31$800.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28
$1.29M
derived: sum of 2 quarters · filed 2016-03-28
$1.41M
derived: sum of 3 quarters · filed 2016-03-28
$1.69M
10-K · filed 2016-03-28
2014-09-30$487.25K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
$610.50K
derived: sum of 2 quarters · filed 2015-11-02
$885.86K
10-Q · filed 2015-11-02
$1.42M
derived: sum of 4 quarters · filed 2015-11-02
2014-06-30$123.25K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30
$398.61K
10-Q · filed 2015-07-30
$933.21K
derived: sum of 3 quarters · filed 2015-07-30
$1.20M
derived: sum of 4 quarters · filed 2015-07-30
2014-03-31$275.36K
10-Q · filed 2015-05-04
$809.96K
derived: sum of 2 quarters · filed 2015-05-04
$1.08M
derived: sum of 3 quarters · filed 2015-05-04
2013-12-31$534.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23
$802.42K
derived: sum of 2 quarters · filed 2015-03-23
$936.51K
10-K · filed 2015-03-23
2013-09-30$267.82K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30
$401.91K
10-Q · filed 2014-10-30
2013-06-30$134.09K
10-Q · filed 2014-08-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
BIOVIE INC. (BIVI)United States$0.012B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33